Bolt Biotherapeutics . Stock Forecast

Hold candidate since Jul 17, 2026 Gain 1.24%

The Bolt Biotherapeutics, Inc. stock price gained 1.24% on the last trading day (Monday, 20th Jul 2026), rising from $4.42 to $4.48. It has now gained 5 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 3.92% from a day low at $4.33 to a day high of $4.50. The price has risen in 6 of the last 10 days and is up by 11.6% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 5 thousand more shares were traded than the day before. In total, 21 thousand shares were bought and sold for approximately $93.23 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -18.59% during the next 3 months and, with a 90% probability hold a price between $2.99 and $3.85 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

BOLT Signals & Forecast

The Bolt Biotherapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $4.12 and $4.33. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, July 10, 2026, and so far it has risen 18.39%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Bolt Biotherapeutics, Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Bolt Biotherapeutics, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $4.21 and $4.01. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Bolt Biotherapeutics, Inc. finds support just below today's level at $4.21. If this is broken, then the next support from accumulated volume will be at $4.01 and $3.99.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.170 between high and low, or 3.92%. For the last week, the stock has had daily average volatility of 6.59%.

Our recommended stop-loss: $4.32 (-3.56%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 6 days ago.)

Trading Expectations (BOLT) For The Upcoming Trading Day Of Tuesday 21st

For the upcoming trading day on Tuesday, 21st we expect Bolt Biotherapeutics, Inc. to open at $4.44, and during the day (based on 14 day Average True Range), to move between $4.33 and $4.62, which gives a possible trading interval of +/-$0.280 (+/-6.47%) up or down from last closing price. If Bolt Biotherapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 6.47% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $4.61 (3.02%) than the support at $4.21 (5.92%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Bolt Biotherapeutics, Inc. stock A Buy?

Bolt Biotherapeutics, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on July 21, 2026 - $4.44 ( 0.89%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk